Siglent Technologies (688112.SH) has released a new product, the SSG3000X Plus series RF signal generator.
Dingyang Technology (688112.SH) announced on June 29, 2026, the company launched the SSG3000X Plus series RF signal generator. This series covers a frequency range of 9kHz to 3.2GHz, with a maximum output power of +20dBm. It offers optional high stability OCXO reference source, excellent phase noise and spurious performance, improved pulse signal fidelity, providing cleaner signal output and more stable performance. It can be widely used in RF component characterization, receiver testing, production manufacturing, education, and maintenance.
Siglent Technologies (688112.SH) announced on June 29, 2026, that the company has launched the SSG3000X Plus series RF signal generator. This series covers a frequency range of 9kHz to 3.2GHz, with a maximum output power of +20dBm. It offers optional high-stability OCXO reference source, excellent phase noise and low noise, and improved pulse signal fidelity, resulting in cleaner signal output and more stable performance. It can be widely used in RF device characterization, receiver testing, production manufacturing, education, and maintenance fields.
The release of this new product showcases the company's technological innovation and product development capabilities, further enriches the company's product matrix and forms, expands the application scenarios and range of the company's products, and will help strengthen and enhance the company's overall competitiveness, positively impacting the company's future development.
Related Articles

BOSS ZHIPIN-W (02076) spent approximately 3 million US dollars on repurchasing 464,800 shares on June 30th.

PT INTL DEV (00372) released its annual performance, with a net loss attributable to shareholders of HK$250 million, an increase of 42.25% year-on-year.

Shanghai Yizhong Pharmaceutical (688091.SH) plans to repurchase company shares worth 30 million to 50 million yuan.
BOSS ZHIPIN-W (02076) spent approximately 3 million US dollars on repurchasing 464,800 shares on June 30th.

PT INTL DEV (00372) released its annual performance, with a net loss attributable to shareholders of HK$250 million, an increase of 42.25% year-on-year.

Shanghai Yizhong Pharmaceutical (688091.SH) plans to repurchase company shares worth 30 million to 50 million yuan.

RECOMMEND





